Azitra, Inc. (NYSE:AZTR)

Health Care/Life Sciences • Biotechnology

CIK 1701478

Company

Azitra, Inc. is an early-stage clinical biopharmaceutical company, which engages in the development of therapeutic use in dermatology. The firm is involved in using engineered proteins and live bio therapeutic products that can be applied topically to treat diseases of the skin. It also offers a platform which is augmented by artificial intelligence and machine learning technology that analyzes, predicts, and helps screen library of strains for drug like molecules. The company was founded by Azim Munivar and Travis Whitfill on January 2, 2014 and is headquartered in Branford, CT.

Address
21 Business Park Drive
Branford, Connecticut 06405

Employees
10

Stock Info

Close
$0.22

Day Range
0.22 - 0.24

52 Week Range
0.20 - 5.18

Average volume
362.31K

Short Interest
65.64K (02/15/24)

% of Float Shorted
0.97%

Market Cap
$6.62M

Revenue
$284K

Net Income
-$10.68M

2020 Sales Growth
N/A

Rev. per Employee
$28.40K

P/E Ratio
N/A

EPS
N/A

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

President, Chief Executive Officer & Director
Francisco D Salva

Chief Operating Officer & Director
Travis Whitfill

Independent Director
Andrew Cain McClary MD

Independent Director
Barbara Ann Ryan

Independent Director
John R Schroer MBA

SEC filings

Date	Form	Event
12 Aug, 2024	10-Q
12 Aug, 2024	8-K
2 Aug, 2024	SC 13D/A
1 Aug, 2024	SC 13G
29 Jul, 2024	SC 13G
26 Jul, 2024	8-K
25 Jul, 2024	424B5
23 Jul, 2024	EFFECT
23 Jul, 2024	CORRESP
23 Jul, 2024	CORRESP
19 Jul, 2024	S-1/A
15 Jul, 2024	FWP
15 Jul, 2024	S-1
8 Jul, 2024	EFFECT
5 Jul, 2024	S-3/A
5 Jul, 2024	CORRESP
3 Jul, 2024	8-K
2 Jul, 2024	UPLOAD
1 Jul, 2024	S-3
18 Jun, 2024	UPLOAD
14 Jun, 2024	DRS
3 Jun, 2024	DEF 14A
24 May, 2024	PRE 14A
9 May, 2024	10-Q
9 May, 2024	8-K
29 Apr, 2024	10-K/A
1 Apr, 2024	4
15 Mar, 2024	10-K
15 Mar, 2024	8-K
27 Feb, 2024	SC 13G
26 Feb, 2024	SC 13G/A
26 Feb, 2024	SC 13G
15 Feb, 2024	4
15 Feb, 2024	4
15 Feb, 2024	4
15 Feb, 2024	424B5
14 Feb, 2024	8-K
13 Feb, 2024	EFFECT
12 Feb, 2024	SC 13G
9 Feb, 2024	CORRESP
9 Feb, 2024	CORRESP
11 Jan, 2024	UPLOAD
4 Dec, 2023	S-8
14 Nov, 2023	10-Q
14 Nov, 2023	8-K
3 Oct, 2023	4
3 Oct, 2023	4
3 Oct, 2023	4
3 Oct, 2023	4
14 Aug, 2023	8-K
14 Aug, 2023	10-Q
24 Jul, 2023	3
24 Jul, 2023	4
11 Jul, 2023	8-K
7 Jul, 2023	8-K
3 Jul, 2023	SC 13D
29 Jun, 2023	4/A
26 Jun, 2023	4
23 Jun, 2023	4
23 Jun, 2023	4
23 Jun, 2023	4
23 Jun, 2023	4
21 Jun, 2023	8-K
21 Jun, 2023	424B4	IPO completed
15 Jun, 2023	3
15 Jun, 2023	EFFECT
15 Jun, 2023	3
15 Jun, 2023	3
15 Jun, 2023	3
15 Jun, 2023	3
15 Jun, 2023	3
15 Jun, 2023	3
15 Jun, 2023	3
13 Jun, 2023	CORRESP
13 Jun, 2023	CORRESP
13 Jun, 2023	CORRESP
13 Jun, 2023	UPLOAD
13 Jun, 2023	S-1/A
5 Jun, 2023	FWP
5 Jun, 2023	S-1/A
31 May, 2023	CORRESP
30 May, 2023	CORRESP
30 May, 2023	CORRESP
26 May, 2023	CORRESP
22 May, 2023	CORRESP
22 May, 2023	CORRESP
17 May, 2023	CERT
17 May, 2023	CORRESP
16 May, 2023	S-1/A
16 May, 2023	8-A12B
15 May, 2023	CORRESP
15 May, 2023	CORRESP
9 May, 2023	S-1/A
28 Apr, 2023	FWP
11 Apr, 2023	FWP
10 Apr, 2023	S-1/A
10 Apr, 2023	CORRESP
3 Apr, 2023	UPLOAD
27 Mar, 2023	FWP
20 Mar, 2023	CORRESP
20 Mar, 2023	S-1/A
10 Mar, 2023	UPLOAD
21 Feb, 2023	S-1
21 Feb, 2023	CORRESP
16 Jan, 2023	UPLOAD
15 Dec, 2022	DRS
12 Oct, 2022	D
19 Jan, 2021	D

Last update:2024-03-06 12:25:44.566189

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.